VTRS News and Press, Viatris Inc. From 05/08/23

2023-05-08 10:57:48 ET Summary Viatris has struggled to gain ground over the last year. This has happened despite management stressing the free cash flow generation ability of the business. Q1-2023 results showed just how much work management needs to do to make this a comebac...

2023-05-08 10:31:29 ET Summary Viatris Inc. reports 5th consecutive quarterly sales decline. Q1 saw the company's 2nd highest free cash flow as a stand-alone. The Viatris dividend appears safe, but increases may need to wait with sales concerns. I recommend waiting at leas...

2023-05-08 07:47:09 ET Viatris press release ( NASDAQ: VTRS ): Q1 GAAP EPS of $0.19 Revenue of $3.72B (-11.2% Y/Y) misses by $90M . U.S. GAAP Net Earnings of $225 million; Adjusted EBITDA of $1.34 billion; U.S. GAAP Net Cash Provided by Operating Act...

2023-05-08 07:41:02 ET Indicating a ~11% YoY decline in total revenue, Viatris ( NASDAQ: VTRS ) continued to report declining sales for the fifth consecutive quarter with its Q1 2023 financials on Monday while signaling a potential recovery in the years ahead. VTRS, established ...

2023-05-08 07:00:00 ET Summary Fuji Pharma Co., Ltd. is mainly a generics pharma company focused on the less volatile Japanese generics market, whose market structure is associated with less regulatory risks, competition, and generics profitability risks. Its generics focus is a p...

Viatris Reports Strong Financial and Operational Results for First Quarter 2023 and Reaffirms Full-Year 2023 Guidance Ranges[1] PR Newswire Reports Total Revenues of $3.73 billion ; U.S. GAAP Net Earnings of $225 million ; Adjusted EBITDA of $1.34 billion ; U.S. ...

2023-05-05 14:00:36 ET Earnings season continues next week, although the pace of releases begins to slow. Entertainment companies provide key highlights during the period, with reports due out from Disney ( DIS ) and Fox ( FOX ). Outside of media, both the pharmaceutical and EV ...

2023-05-05 11:24:04 ET Viatris ( NASDAQ: VTRS ) is scheduled to announce Q1 earnings results on Monday, May 8th, before market open. The consensus EPS Estimate is $0.70 (+112.1% Y/Y) and the consensus Revenue Estimate is $3.81B (-9.1% Y/Y). Over the last 1 year, VTRS h...

2023-05-04 14:28:38 ET Summary Organon reported obviously disappointing results today - OGN stock plunged more than 10% in response. In this update, I share my view on Organon's quarterly results and point out possible warning signs and reasons for the sell-off. I give an upda...

2023-04-27 09:45:00 ET If you have $20,000 or more in savings that you can afford to invest in stocks, you may want to consider putting that in some high-yielding investments that can provide you with some great recurring income. Viatris (NASDAQ: VTRS) and AT&T (NYSE: ...